Overdosage of pamidronate in a patient with renal cell carcinoma.
Akbulut
H
H
Department of Medical Oncology, Faculty of Medicine, Ankara University, Turkey. hakbulut@dialup.ankara.edu.tr
Icli
F
F
D000368:Aged; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage / Q000009:adverse effects*; D002292:Carcinoma, Renal Cell / Q000150:complications*; D004164:Diphosphonates / Q000008:administration & dosage / Q000009:adverse effects*; D005260:Female; D006801:Humans; D006934:Hypercalcemia / Q000188:drug therapy* / Q000209:etiology; D007262:Infusions, Intravenous; D007680:Kidney Neoplasms / Q000150:complications*; D000077268:Pamidronate
D000893:Anti-Inflammatory Agents; D004164:Diphosphonates; D000077268:Pamidronate